Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Sergio Vano-Galvan"'
Autor:
Michela Starace, PhD, Matilde Iorizzo, PhD, Andrea Sechi, MD, Aurora Maria Alessandrini, MD, Miriam Carpanese, MD, Francesca Bruni, MD, Giulio Vara, MD, Zoe Apalla, MD, Daniel Asz-Sigall, MD, Stefania Barruscotti, MD, Francisco Camacho, PhD, Isabella Doche, PhD, Bruna Duque Estrada, MD, Rachita Dhurat, MD, Maria Fernanda Gavazzoni, MD, Ramon Grimalt, PhD, Matthew Harries, MD, Dimitrios Ioannidis, MD, Amy McMichael, MD, Daniel Fernandes Melo, PhD, Rui Oliveira, MD, Yuliya Ovcharenko, MD, Rodrigo Pirmez, PhD, Yuval Ramot, PhD, Lidia Rudnicka, PhD, Jerry Shapiro, PhD, Tatiana Silyuk, MD, Rodney Sinclair, PhD, Antonella Tosti, PhD, Sergio Vano-Galvan, PhD, Bianca Maria Piraccini, PhD
Publikováno v:
JAAD International, Vol 5, Iss , Pp 11-18 (2021)
Background: The cutaneous manifestations of COVID-19 may be useful disease markers and prognostic indicators. Recently, postinfectious telogen effluvium and trichodynia have also been reported. Objective: To evaluate the presence of trichodynia and t
Externí odkaz:
https://doaj.org/article/6110f51ddda6484fa7a6a7ea3edcd098
Autor:
Natasha Atanaskova Mesinkovska, Brett A. King, Sergio Vañó‐Galván, Yutaka Shimomura, Jakub Jedynak, Jill McCollam, Evangeline Pierce, Amy K. Ellinwood, Rodney Sinclair
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 2, Pp 528-535 (2024)
Abstract Background The Severity of Alopecia Tool (SALT) is a standardized method for quantifying scalp hair loss in alopecia areata (AA). SALT scores can be used to guide treatment decisions and are widely used as eligibility criteria and endpoints
Externí odkaz:
https://doaj.org/article/10df0df3e50e45c29038a20cd9d1845a
Autor:
Wilma F. Bergfeld, Maria K. Hordinsky, S. Papanikou, Giselle Martins Pinto, Isabella Doche, Satoshi Itami, S. Malakar, K. Khobzei, Elise A. Olsen, Paradi Mirmirani, T. Silyuk, V. Chasapi, Rod Sinclair, Valerie D. Callender, Amy J. McMichael, Kenneth Washenik, Matthew Harries, R. O. Soares, Rodrigo Pirmez, N. Enechukwu, Lidia Rudnicka, Ulrike Blume-Peytavi, Won Soo Lee, Abraham Zlotogorski, Pascal Reygagne, David Saceda-Corralo, Yuliya Ovcharenko, Jerry Shapiro, A. Souissi, George Cotsarelis, Ramon Grimalt, O. Correia, Antonella Tosti, Douglas Canfield, Ncoza C. Dlova, Sergio Vano-Galvan, Annika Vogt, Rachita Dhurat, Andrew G. Messenger, Bianca Maria Piraccini, Janet L. Roberts
Publikováno v:
British Journal of Dermatology. 185:1221-1231
Background Frontal fibrosing alopecia (FFA) has become one of the most common causes of cicatricial alopecia worldwide. However, there is a lack of clear aetiology and robust clinical trial evidence for the efficacy and safety of agents currently use
Autor:
David Saceda-Corralo, Juan Jimenez-Cauhe, Sergio Vano-Galvan, Anna Waskiel-Burnat, Michela Starace, Kristen LoSicco, Rebekka Jerjen, Rodrigo Pirmez, Bianca Maria Piraccini, Rita Rodrigues-Barata, Pedro Jaén-Olasolo, Antonella Tosti, Janina Eliza Poa, Lu Yin, Rodney Sinclair, Lara Trindade de Carvalho, Lidia Rudnicka, Bevin Bhoyrul, Wei L. Koh, Colombina Vincenzi, José Luis Zamorano, Oscar M. Moreno-Arrones, Corina Isabel Salas-Callo, Jerry Shapiro, Jared Marc John, Ángela Hermosa-Gelbard
Publikováno v:
Journal of the American Academy of Dermatology. 84:1644-1651
Background The major concern regarding the use of low-dose oral minoxidil (LDOM) for the treatment of hair loss is the potential risk of systemic adverse effects. Objective To describe the safety of LDOM for the treatment of hair loss in a large coho
Autor:
Sonia Chavez-Alvarez, Sonia Sofia Ocampo-Garza, Jorge Ocampo-Candiani, Maira Elizabeth Herz-Ruelas, Valeria Olvera-Rodríguez, Thelma Laura Orizaga-Y-Quiroga, Sergio Vano-Galvan
Publikováno v:
Skin Appendage Disord
Frontal fibrosing alopecia (FFA) is an acquired primary lymphocytic cicatricial alopecia characterized by frontotemporal hairline recession, leading to scarring alopecia with a band-like distribution. Prevalence is increasing worldwide, being the mos
Autor:
Florence Pouradier, Mariya Nevskaya, Kamila Padlewska, Michaela Havlíčková, Victor Desmond Mandel, Pascal Reygagne, Veronique Meuleman, Sergio Vano-Galvan, Delphine Kerob, Catherine Delva, Rose Khalil, Jean-François Michelet, Gilberto Adame Miranda
Publikováno v:
Dermatologic therapy. 34(6)
Introduction Androgenic alopecia (AGA) is a common and chronic condition. It may impact self-esteem, self-image and quality of life. Benefit, tolerability, cosmetic acceptance and patient satisfaction are key to ensuring good treatment outcome. Aim A
Autor:
Sineida Berbert ferreira, Tracy L. Davis, Wendy Ridenour, Kimberly Aleen Artounian, Antonella Tosti, Andy Goren, Ryan R. Falsey, Carlos Gustavo Wambier, Tatiana F. Abrantes, Sergio Vano-Galvan, João Carlos Lopes Simão
Publikováno v:
Journal of the American Academy of Dermatology
Autor:
Rachita Dhurat, Suraj Pai, John McCoy, Sergio Vano-Galvan, Sanober Burzin Daruwalla, Andy Goren, Jerry Shapiro, Rod Sinclair, Maja Kovacevic
Publikováno v:
Journal of cosmetic dermatologyREFERENCES. 21(1)
Background Minoxidil is a widely used over-the-counter topical treatment for hair loss. The response rate for topical minoxidil is relatively low. Minoxidil is a pro-drug, converted to its active form, minoxidil sulfate, by SULT1A1 enzymes located in
Autor:
Gerald Selda-Enriquez, Ana Melian-Olivera, David Saceda-Corralo, Laura Miguel-Gomez, Patricia Burgos-Blasco, Ana Suarez-Valle, Sergio Vano-Galvan
Publikováno v:
Journal of the American Academy of Dermatology. 87(1)
Autor:
Rodney Sinclair, Andy Goren, Sergio Vano-Galvan, Maja Kovacevic, Jerry Shapiro, Mohamad Goldust, Mirna Šitum, John McCoy
Publikováno v:
Journal of Cosmetic Dermatology. 19:2647-2649
Background: Topical minoxidil is the only US FDA- approved drug for the treatment of female pattern hair loss (FPHL). While the safety profile of topical minoxidil is excellent, the efficacy of minoxidil in hair growth is extremely low. A recent surv